Teva Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Teva Pharmaceuticals

TEVA 20.48

+2.2%

Oct 31 9:30 AM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: flatsville who wrote (295)	12/18/2001 6:36:07 AM
From: Dorine Essey	Read Replies (1) of 340

Teva((TEVA.O)) Has Final FDA Ok for Cholesterol Drug December 18, 2001 03:35:17 (ET) TEL AVIV, Dec 18 (Reuters) - Israel's Teva Pharamceutical Industries said on Tuesday it received final approval from the U.S. Food and Drug Administration to market Lovastatin, a generic version of Merck & Co's (MRK,Trade) cholesterol-lowering Mevacor. This follows the expiration of Merck's period of pediatric exclusivity for Mevacor. Teva had originally received approval in June 2001 but the FDA subsequently awarded six months pediatric exclusivity to Merck. Annual sales of Mevacor are estimated at $200 million and Teva said it will launch Lovastatin immediately in tablets of 10, 20 and 40 mg.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next